Dr. Phil Davidson Named Medical Director of Arcuro Medical; Dr. Ken Zaslav Joins Arcuro Scientific Advisory Board
Retrieved on:
Monday, March 21, 2022
Company, Clinical, Leadership, Past, Weill Cornell Medicine, Consultant, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, United States Air Force Scientific Advisory Board, Harvard College, Research, Orthopedic surgery, Medical director, CEO, Sports medicine, Shoulder, MD, Injury, Virginia Commonwealth University, Center, Freshwater Biological Association, Association, Hofstra University, Surgeon, Knee, SGX, SAB, Athlete, FDA, Publishing, Dentistry
MISGAV, Israel, March 21, 2022 /PRNewswire/ -- Arcuro Medical Ltd. ( www.arcuromedical.com ), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), today announced the appointment of Dr. Phil Davidson as Medical Director and Chair of the Company's Scientific Advisory Board ("SAB").
Key Points:
- MISGAV, Israel, March 21, 2022 /PRNewswire/ -- Arcuro Medical Ltd. ( www.arcuromedical.com ), a portfolio company of The Trendlines Group (SGX: 42T) (OTCQX: TRNLY), today announced the appointment of Dr. Phil Davidson as Medical Director and Chair of the Company's Scientific Advisory Board ("SAB").
- Dr. Ken Zaslav joins Dr. Davidson as a founding member of the SAB.
- The founding members of the Arcuro SAB are Dr. Phil Davidson and Dr. Ken Zaslav.
- Dr. Davidson graduated from Harvard College and received his MD degree with Honors in Research from Cornell University Medical College.